Activity: Industry, Government and Philanthropy Engagement and Partnerships › Patents › Patent
Inhibitors of protease activated receptor-2
Abstract: The present invention relates generally to compounds capable of inhibiting Protease Activated Receptor-2 (PAR2), and uses thereof. More specifically, the present invention relates to inhibitors of PAR2, to their preparation, and to their use in the treatment of diseases and disorders mediated by PAR2 signaling.
WO2019124567A1 - WIPO (PCT) Application PCT/JP2018/047988 events 2017-12-20 Priority to AU2017905084A 2017-12-20 Priority to AU2017905084 2018-12-19 Application filed by Takeda Pharmaceutical Company Limited 2019-06-27 Publication of WO2019124567A1